This journal scan presents recent advances in pharmacotherapy, including obicetrapib, tirzepatide, plozasiran, and solbinsiran. It also discusses polymeric heart valves and demographic thresholds for hypertrophy in the diagnosis of obstructive hypertrophic cardiomyopathy. Additionally, we highlight important trials presented at the EURO PCR 2025, held in Paris, France.
📖 افتح في inklap 🔗 DOI 📮 اطلب بحثاً